These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 33835131)

  • 1. Revolutionizing enzyme engineering through artificial intelligence and machine learning.
    Singh N; Malik S; Gupta A; Srivastava KR
    Emerg Top Life Sci; 2021 May; 5(1):113-125. PubMed ID: 33835131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machine learning-assisted enzyme engineering.
    Siedhoff NE; Schwaneberg U; Davari MD
    Methods Enzymol; 2020; 643():281-315. PubMed ID: 32896285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revolutionizing Molecular Design for Innovative Therapeutic Applications through Artificial Intelligence.
    Son A; Park J; Kim W; Yoon Y; Lee S; Park Y; Kim H
    Molecules; 2024 Sep; 29(19):. PubMed ID: 39407556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Progress in the application of artificial intelligence-assisted molecular modification of enzymes].
    Xu P; Wang W; Ning H; Cao R; Liu S; Fan P; Song X
    Sheng Wu Gong Cheng Xue Bao; 2024 Jun; 40(6):1728-1741. PubMed ID: 38914488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A primer on applying AI synergistically with domain expertise to oncology.
    Kim J; Kusko R; Zeskind B; Zhang J; Escalante-Chong R
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188548. PubMed ID: 33901609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Machine Learning and Artificial Intelligence: A Paradigm Shift in Big Data-Driven Drug Design and Discovery.
    Pasrija P; Jha P; Upadhyaya P; Khan MS; Chopra M
    Curr Top Med Chem; 2022; 22(20):1692-1727. PubMed ID: 35786336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the artificial intelligence and machine learning models in the context of drug design difficulties and future potential for the pharmaceutical sectors.
    Shiammala PN; Duraimutharasan NKB; Vaseeharan B; Alothaim AS; Al-Malki ES; Snekaa B; Safi SZ; Singh SK; Velmurugan D; Selvaraj C
    Methods; 2023 Nov; 219():82-94. PubMed ID: 37778659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein-DNA/RNA interactions: Machine intelligence tools and approaches in the era of artificial intelligence and big data.
    Cui F; Zhang Z; Cao C; Zou Q; Chen D; Su X
    Proteomics; 2022 Apr; 22(8):e2100197. PubMed ID: 35112474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Democratizing Artificial Intelligence Imaging Analysis With Automated Machine Learning: Tutorial.
    Thirunavukarasu AJ; Elangovan K; Gutierrez L; Li Y; Tan I; Keane PA; Korot E; Ting DSW
    J Med Internet Res; 2023 Oct; 25():e49949. PubMed ID: 37824185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of artificial intelligence to enzyme and pathway design for metabolic engineering.
    Jang WD; Kim GB; Kim Y; Lee SY
    Curr Opin Biotechnol; 2022 Feb; 73():101-107. PubMed ID: 34358728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PyPEF-An Integrated Framework for Data-Driven Protein Engineering.
    Siedhoff NE; Illig AM; Schwaneberg U; Davari MD
    J Chem Inf Model; 2021 Jul; 61(7):3463-3476. PubMed ID: 34260225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Big data and machine learning driven bioprocessing - Recent trends and critical analysis.
    Yang CT; Kristiani E; Leong YK; Chang JS
    Bioresour Technol; 2023 Mar; 372():128625. PubMed ID: 36642201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artificial Intelligence as Accelerator for Genomic Medicine and Planetary Health.
    Gulfidan G; Beklen H; Arga KY
    OMICS; 2021 Dec; 25(12):745-749. PubMed ID: 34780300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics.
    Koromina M; Pandi MT; Patrinos GP
    OMICS; 2019 Nov; 23(11):539-548. PubMed ID: 31651216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applications of artificial intelligence and machine learning in dynamic pathway engineering.
    Merzbacher C; Oyarzún DA
    Biochem Soc Trans; 2023 Oct; 51(5):1871-1879. PubMed ID: 37656433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The recent advances in the approach of artificial intelligence (AI) towards drug discovery.
    Khan MK; Raza M; Shahbaz M; Hussain I; Khan MF; Xie Z; Shah SSA; Tareen AK; Bashir Z; Khan K
    Front Chem; 2024; 12():1408740. PubMed ID: 38882215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artificial intelligence in spine care: current applications and future utility.
    Hornung AL; Hornung CM; Mallow GM; Barajas JN; Rush A; Sayari AJ; Galbusera F; Wilke HJ; Colman M; Phillips FM; An HS; Samartzis D
    Eur Spine J; 2022 Aug; 31(8):2057-2081. PubMed ID: 35347425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery.
    Yang X; Wang Y; Byrne R; Schneider G; Yang S
    Chem Rev; 2019 Sep; 119(18):10520-10594. PubMed ID: 31294972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Machine Learning for Biologics: Opportunities for Protein Engineering, Developability, and Formulation.
    Narayanan H; Dingfelder F; Butté A; Lorenzen N; Sokolov M; Arosio P
    Trends Pharmacol Sci; 2021 Mar; 42(3):151-165. PubMed ID: 33500170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial intelligence as an emerging technology in the current care of neurological disorders.
    Patel UK; Anwar A; Saleem S; Malik P; Rasul B; Patel K; Yao R; Seshadri A; Yousufuddin M; Arumaithurai K
    J Neurol; 2021 May; 268(5):1623-1642. PubMed ID: 31451912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.